Foster McKay’s Post

Check out our latest article on how taxes can impact your biopharma licensing deal and provide an competitive edge in negotiations.

🌿 Unlocking Financial Growth in the Cannabis Industry! 📊 Dive into the world of #TaxPlanning and Accounting Services for the Cannabis Industry with StubsonDemand. 👉 Read the full article by Hassan Tariq: https://lnkd.in/e-ufynE2 🌐 The cannabis sector is booming, but navigating the complex tax landscape is crucial. Discover legal strategies to minimize tax liabilities and optimize financial positions. 📌 Key Highlights: ✅ 280E Restrictions ✅ Meticulous Accounting Practices ✅ Tax Planning Strategies ✅ Oklahoma's Evolving Taxation Laws 💼 Cannabis businesses, face the unique challenge of Section 280E. Learn how hiring a specialized CPA, like Epsilon Accounting Solutions in Edmond, can be a game-changer. 📚 Stay informed and compliant in this evolving industry. Share your thoughts and explore the financial world of cannabis! 💬 #CannabisIndustry #TaxAndAccounting #Finance #Legal #StubsonDemand #EpsilonAccountingSolutions #OklahomaTax #FinancialManagement#EpsilonAccountingSolutions

Taxes are often overlooked in dealmaking. That is a shame because there can be room to bridge gaps or optimize the deal for both sides. In Rival software you can easily run scenarios to find the right structure.

How Taxes Shape Biotech & Pharma Licensing Deals: 💡Maximize Value with Smart Strategies 💡 In the biotech and pharmaceutical industries, licensing deals are crucial for bringing innovative therapies to market, but one often-overlooked factor that can greatly impact these deals is taxes. Whether you're a biotech innovator or a pharma giant, understanding how tax regimes affect your financial outcomes is key to optimizing licensing agreements. For licensees in low-tax environments, the increased post-tax earnings offer room for more attractive deal terms. On the other hand, biotech licensors in favourable tax jurisdictions can maximize shareholder returns by leveraging tax benefits in negotiations. 🔎 Run Tax Simulations to Unlock Hidden Value 🔎 At Avance, we’ve seen how running tax simulations using RIVAL software can reveal opportunities for deal optimization. By accounting for both parties’ tax environments, dealmakers can structure agreements that maximize post-tax value. For example, a biotech in a low-tax jurisdiction could negotiate higher royalties, while a pharma company with tax advantages might offer better upfront terms. The goal is to align tax benefits with deal structure, leading to smarter decisions and greater mutual gain. Want to learn more? 👉 Read the full blog here https://lnkd.in/dkdZ4MG3 #BiotechDeals #PharmaIndustry #TaxImpact #Biopharma

Since I’ve joined Marosa, I've been working on helping Pharma, MedTech, and Biotech companies with their VAT compliance. Yes! It is a pain and gets a bit tricky in these industries, especially with the movement of goods during clinical trials or R&D. 👉🏼Here's how I try make VAT compliance easier for VAT Managers and tax professionals: 📊 Focus on creating specific personalised plans for each company to make sure they follow all the VAT rules in different countries, even for complicated transactions. 📊 Our compliance solution helps companies prepare and file VAT returns accurately and on time, so they don't get any fines nor miss any deadlines. 📊 Our software helps companies keep track of everything they need for VAT compliance, like data, returns and deadlines, all in one place. No need to go find all this info in separate sources. If you feel like you've got your VAT compliance under control but still are looking to improve certain gaps or need more help determining your VAT compliance obligations, DM me for more info. #Marosa #VATCompliance #VATTechnology #VAT #Pharma #MedTech #Biotech

A Historic Day with Key Cannabis Industry Updates Yesterday’s U.S. election brought significant shifts, with state-level decisions impacting the cannabis industry: ▶️ North Dakota and South Dakota voters rejected adult-use cannabis legalization proposals. ▶️ Nebraska passed medical cannabis reforms. ▶️ Florida’s adult-use cannabis legalization amendment failed. With a new administration on the horizon, many in the industry are left wondering what comes next. But here’s what I always tell my clients: you need to focus on what you can control. Running a cannabis business means navigating complex regulations and staying proactive. That’s why having comprehensive accounting policies and internal controls is crucial. To help, I’m sharing a free guide that covers essential accounting policies and controls, including: ✔️ Financial Reporting and Oversight ✔️ Cash Management ✔️ Revenue Recognition and Accounts Receivable ✔️ Inventory, Expenses, and Accounts Payable ✔️ Property, Equipment, and Tenant Improvements ✔️ Payroll ✔️ Long-Term Debt ✔️ Deferred Revenue ✔️ Income Taxes ✔️ Risk Assessment and Management 📄 Download the guide attached to this post to ensure your business is set up for success and compliance. Are your accounting policies strong enough to meet industry demands?

Our page is live! 🌱 Curious how Growise CPAs can support your cannabis business? Send me a DM to learn more—your first consultation is FREE! Let’s grow together. ✨

Uncover the key role of a Virtual CFO for your cannabis venture, and the qualities that matter - strategic advice, regulatory expertise, and customized insights. Learn when it's the ideal time to bring one on board. Read our Cannabis CFO's piece for the National Cannabis Industry Association #CannabisBusiness #VirtualCFO